Quick Answer Box
Where do you buy sermorelin in Canada in 2026? The top domestic option is Nox Peptides. They’re currently the only Canadian retail-facing supplier publishing both purity and endotoxin lab reports per batch. Other verified Canadian suppliers carrying research-grade sermorelin include Growth Guys, Canadian Peptides, NCRP, Polar Peptides, Peptide Warehouse, Clinical Peptides, Amino Pure Canada, Purity Peptides, VPeptide, PeptidePro Canada, and Boss Peptides.
Sermorelin essentials:
- What it is: A synthetic 29-amino-acid fragment of growth hormone-releasing hormone (GHRH 1–29). It’s the smallest fragment of natural GHRH that keeps full biological activity at the pituitary GHRH receptor.
- Mechanism: Triggers the pituitary gland to release the body’s own growth hormone in natural pulsatile patterns; doesn’t replace GH directly.
- Status in Canada: Sermorelin is not approved by Health Canada as a current prescription drug. The original brand-name product (Geref) was pulled from the market years ago. Research-grade sermorelin remains available from Canadian peptide suppliers strictly for laboratory research use only.
- Typical research-grade pricing: Roughly CAD $50 to $150 per vial depending on dosage strength and supplier.
- Common research format: 2mg, 5mg, or 10mg lyophilized vials.
All compounds discussed are sold strictly for laboratory research use only, not for human consumption.
What Sermorelin Actually Is — The Original GHRH Fragment
Sermorelin holds a specific historical spot in the GHRH analog category: it was the first synthetic GHRH fragment shown to keep full biological activity. The compound consists of the first 29 amino acids of human GHRH. The minimum sequence needed to bind and switch on the GHRH receptor at the pituitary.
| Property | Value |
|---|---|
| Compound name | Sermorelin (also: GHRH 1–29; Geref; sermorelin acetate) |
| Type | Synthetic GHRH fragment (29 amino acids) |
| Source | The first 29 amino acids of human growth hormone-releasing hormone |
| Half-life | ~10–20 minutes (very short) |
| Mechanism | Binds pituitary GHRH receptors; triggers the body’s own GH release in pulsatile pattern |
| Original brand | Geref (Serono), withdrawn from market |
| Standard research format | Lyophilized powder in 2mg, 5mg, or 10mg vials |
| Reconstitution | Bacteriostatic water |
| Health Canada status | Not currently approved |
| WADA status | Listed under prohibited substances for athletes |
The Short Half-Life Trade-Off
Sermorelin’s defining pharmacological feature is its short half-life of roughly 10–20 minutes. That short window has both upsides and downsides depending on the research question:
| Advantage | Disadvantage |
|---|---|
| Mimics natural pulsatile GH release patterns | Needs daily (or more frequent) administration in research protocols |
| Short systemic exposure cuts sustained-elevation risks | Less convenient than longer-acting GHRH analogs like CJC-1295 with DAC |
| Predictable pulse timing for sleep-cycle GH research | Lower per-dose efficacy than extended-half-life alternatives |
| Lower per-vial cost than newer compounds | More expensive per equivalent biological effect over time |
For Canadian researchers studying naturalistic pulsatile GH release patterns, particularly the sleep-cycle GH pulse that happens during slow-wave sleep, sermorelin’s short half-life is a feature, not a bug. It produces a single discrete GH pulse rather than the sustained elevation produced by longer-acting GHRH analogs.
📊 Sermorelin vs Other GH-Secretagogue Research Peptides
| Compound | Mechanism Class | Half-Life | Best Research Application |
|---|---|---|---|
| Sermorelin (GHRH 1–29) | GHRH fragment, 29 AA | ~10–20 minutes | Pulsatile GH release; sleep-cycle GH research |
| Tesamorelin | Stabilized GHRH analog, 44 AA | ~26 minutes (extended via stabilization) | Visceral fat / lipodystrophy research |
| CJC-1295 (no DAC) | GHRH analog, 30 AA | ~30 minutes | Modified GHRH research |
| CJC-1295 (with DAC) | GHRH analog with extended half-life | ~6–8 days | Sustained GH elevation research |
| Ipamorelin | GHRP / ghrelin mimetic, 5 AA | ~2 hours | Selective GH release without cortisol/prolactin spike |
| MK-677 (Ibutamoren) | Oral ghrelin receptor agonist | ~24 hours | Oral-route GH research |
For comparative GH-secretagogue research, sermorelin sits at one end of the spectrum (shortest half-life, smallest molecule, closest to natural GHRH) while CJC-1295 with DAC sits at the other end (longest half-life, sustained pharmacological action). Researchers comparing pulsatile vs. sustained GH release models typically use both compounds as reference points.
🎥 Watch: Growth Hormone-Releasing Peptides Explained
Dr. Andrew Huberman’s lecture covers the major categories of peptides currently in use for therapeutic and research purposes, including GHRH analogs and growth hormone secretagogues like sermorelin. A solid reference for understanding the GH-related peptide research category.
The Canadian Regulatory Picture for Sermorelin in 2026
Sermorelin’s regulatory status in Canada has shifted over the past two decades. The original brand-name product, Geref, was once approved for diagnostic use in pediatric growth hormone deficiency assessment. That product has since been pulled from the Canadian market, and no replacement brand has been approved.
The current regulatory framework:
| Category | Status | Implication for Buyers |
|---|---|---|
| Approved drug status | None currently in Canada | No prescription pathway for sermorelin in 2026 |
| Compounding pharmacy availability | Limited; not widely compounded in Canada | Different from US market where compounding has been more common |
| Research chemical category | Available from Canadian peptide suppliers | Strictly for laboratory research use only; not for human consumption |
| WADA status | Prohibited substance | Athletes under WADA Code can’t source, possess, or use |
Until any sermorelin product receives Health Canada approval (or returns to approval), the compound exists in Canada strictly within the research-chemical category. Sold to qualified buyers for laboratory and in-vitro experimental use, not for human or animal administration.
Why Researchers Still Source Sermorelin in 2026
Despite newer compounds with longer half-lives and improved convenience profiles, sermorelin demand has stayed strong in Canada in 2026. The reasons reflect specific research applications where sermorelin’s properties remain valuable:
| Research Application | Why Sermorelin Specifically |
|---|---|
| Pulsatile GH release modeling | Short half-life produces discrete pulses matching natural physiology |
| Sleep-cycle GH research | Single-pulse pharmacology lines up with slow-wave sleep GH pulse studies |
| Comparative GHRH analog research | Reference compound for longer-acting GHRH analog comparisons (CJC-1295, tesamorelin) |
| Combination protocol research | GHRH + GHRP synergy studies often pair sermorelin with ipamorelin |
| Pediatric GH research models | Historical use as diagnostic tool for pediatric GH deficiency informs ongoing research |
| Cost-sensitive research | Lower per-vial cost than newer compounds for high-volume protocol studies |
The 7-Point Verification Framework for Research-Grade Sermorelin
| # | Verification Signal | Why It Matters for Sermorelin Specifically |
|---|---|---|
| 1 | Independent third-party COA per batch | Janoshik or equivalent is the 2026 standard; self-issued COAs aren’t verification |
| 2 | HPLC purity ≥98% | For 29 AA peptides, ≥98% is the baseline; ≥99% is the upper tier |
| 3 | Mass spectrometry sequence verification | Confirms the GHRH 1–29 fragment is correctly assembled |
| 4 | Endotoxin testing | Bacterial contamination is invisible on purity tests; affects hormone research outcomes |
| 5 | Domestic Canadian shipping | Skips CBSA seizure risk; keeps cold-chain integrity |
| 6 | Research-use-only framing | Vendors marketing for human use are running outside the legal framework |
| 7 | Public lab results page | Vendors hiding COAs behind email-only requests are running opaquely |
1. Nox Peptides — The Documentation Standard
Site: noxpeptides.ca
Standout claim: Only Canadian retail supplier publishing both purity AND endotoxin lab reports on sermorelin
Best for: Researchers who want the deepest documentation chain on the foundational GHRH fragment
Nox Peptides earns the #1 spot because sermorelin research demands documentation depth most Canadian retailers don’t provide. Most suppliers stop at HPLC purity COAs. Nox publishes those reports plus endotoxin testing, a step usually reserved for GMP pharmaceutical manufacturing.
For sermorelin specifically, that documentation depth matters because the compound’s mechanism touches hormonal signaling pathways where endotoxin contamination would independently trigger inflammatory responses, confounding research outcomes that are invisible on a standard purity COA. While sermorelin is a smaller peptide than tesamorelin or retatrutide, the same documentation principles apply: synthesis quality, batch-to-batch consistency, and contamination control all influence research outcomes.
The Nox brand framing leans engineering-first: NØX is a performance science system engineered for measurable human output, designing, synthesizing, and validating precision performance compounds with documented traceability and authorized release. The catalog covers the full GH-secretagogue category. Research-grade sermorelin alongside CJC-1295, tesamorelin, ipamorelin, and MK-677, which makes comparative GH-secretagogue research from a single supplier doable.
What you actually get with Nox sermorelin:
- Per-batch purity reports verified by an independent third-party lab
- Per-batch endotoxin reports, invisible on standard COAs at every other Canadian retailer
- Mass spectrometry sequence verification, confirming all 29 amino acids of the GHRH fragment
- Domestic Canadian dispatch with Canadian customer service
- Catalog adjacency: full GH-secretagogue category for comparative research
Browse the research-grade sermorelin listing and per-batch lab reports at noxpeptides.ca.
2. Growth Guys — GH-Specialty Vendor with Janoshik Verification
Site: growthguys.is
Catalog focus: Growth hormone-related compounds with Janoshik public batch verification
Growth Guys is named for what they specialize in, and sermorelin sits squarely in their wheelhouse. The vendor has built a strong Canadian peptide community reputation specifically around Janoshik Analytical batch testing, with verifiable purity data published per product variant. The catalog leans heavily on growth hormone-related peptides (sermorelin, CJC-1295, tesamorelin, ipamorelin, GHRP-2, GHRP-6, MK-677) alongside the broader research peptide range.
For sermorelin specifically, the Janoshik verification matters because anyone can publish a PDF COA. Janoshik’s public verification system at janoshik.com lets researchers look up specific batch results independently using a unique key, confirming the supplier’s published COA matches the actual lab report. For researchers building comparative GH-secretagogue protocols, Growth Guys’ specialty in this category is meaningful.
3. Canadian Peptides — Established Generalist with Full GH-Class Coverage
Site: canadianpeptides.ca
Catalog focus: Long-running domestic generalist with broad GH-secretagogue inventory
Canadian Peptides has been one of the longer-running domain names in this space and carries broad GH-secretagogue inventory. Sermorelin alongside tesamorelin, CJC-1295 (with and without DAC), ipamorelin, and MK-677. They market a 99%+ purity standard with lab-tested and COA verified products, plus fast shipping across Canada.
For researchers building comparative GH-secretagogue studies, particularly those who want to study sermorelin alongside its longer-acting analog cousins, Canadian Peptides offers a meaningful single-vendor inventory edge. The product framing is research-clear with consistent disclaimer language across the catalog: for research use only, not for human consumption, medical use, or diagnostic applications.
4. NCRP (National Canadian Research Peptides) — Manufacturer-Direct Transparency
Site: ncrpcanada.com
Catalog focus: Manufacturer-direct sourcing with detailed published handling protocols
NCRP runs one of the more transparent manufacturer-direct outfits in the Canadian market. All of their products are made in Canada and certified greater than 98% pure by HPLC, with mass spectroscopy used to confirm sequence accuracy.
What sets NCRP apart isn’t just the testing standard. It’s the operational documentation depth published alongside the catalog. Their handling guidance is unusually detailed: peptides should be stored in a dry, cool, dark place, with refrigeration at 4°C or colder away from bright light recommended for best preservation, and reconstituted only with bacteriostatic water using an insulin needle and gentle injection technique. For sermorelin specifically, a peptide with relatively unstable post-reconstitution behavior, that handling guidance matters.
5. Polar Peptides — Education-Heavy Sourcing
Site: polarpeptides.ca
Catalog focus: Detailed product education modules across the GH-secretagogue category
Polar Peptides has built itself out as one of the most education-focused Canadian suppliers, with detailed product framing across the GH-secretagogue category. Their sermorelin listing publishes full molecular profiles, vial dimensions, fill percentages, and reconstitution guidance. Operational details that signal serious quality control.
For researchers entering the GH-secretagogue category for the first time, Polar’s educational layer helps clarify the meaningful differences between GHRH fragments (sermorelin), stabilized GHRH analogs (tesamorelin), GHRH analogs with extended half-life (CJC-1295 with DAC), and GHRP / ghrelin mimetics (ipamorelin, MK-677). Standard logistics: orders ship within 24 hours Monday–Friday from a Canadian fulfillment centre, with 2–5 business day delivery.
6. Peptide Warehouse — Catalog Breadth
Site: peptidewarehouse.ca
Catalog focus: Broad metabolic and GH-secretagogue inventory
Peptide Warehouse runs one of the broader Canadian metabolic and GH-related peptide catalogs, with research-grade sermorelin alongside the full GH-secretagogue family: CJC-1295 (with and without DAC), tesamorelin, ipamorelin, GHRP-2, GHRP-6, and MK-677. The site advertises HPLC tested products plus a wide range of peptides, bacteriostatic water, and supporting research consumables.
For researchers running comparative studies across the GH-secretagogue class, having all the comparison compounds available from one supplier simplifies sourcing logistics and creates batch-consistency across the experimental panel. Combination blends are also available. Sermorelin can be paired with ipamorelin in pre-formulated research blends, cutting out the need to manually combine compounds post-receipt.
7. Clinical Peptides — Domestic Synthesis + Loyalty Pricing
Site: clinicalpeptides.net (also clinicalpeptides.ca)
Catalog focus: Canadian-synthesized peptides with rewards program economics
Clinical Peptides has leaned into Canadian-domestic synthesis with loyalty mechanics that make sense for repeat sermorelin buyers. Most of their peptides are now made in Canada, synthesized, purified, and completed within Canada, with in-house synthesis and strict adherence to USP-grade excipient standards ensuring purity, consistency, and full traceability.
The loyalty mechanics: for every $1 spent, customers earn 1 point, and every 100 points converts into a $5 discount toward future orders, plus a referral program offering 15% off for new customers and a $20 credit per successful referral. For sermorelin specifically, where short half-life means research protocols often require frequent dosing and therefore higher procurement volumes, the rewards mechanics add up meaningfully.
8. Amino Pure Canada — Format Flexibility
Site: aminopurecanada.ca
Catalog focus: Multiple administration formats for GH-secretagogue compounds
Amino Pure Canada offers research peptides across format options uncommon among Canadian suppliers: capsules, vials, and atomizer sprays. HPLC analysis and GMP manufacturing conditions back every batch at 99%+ purity with full Certificate of Analysis documentation.
Logistics: free shipping on all orders over $200 CAD, plus same-day shipping on orders placed and paid before 2 PM EST, with Canada-wide coverage to Ontario, Quebec, Alberta, and British Columbia. For researchers comparing administration-route bioavailability differences across GH-secretagogue compounds, the format flexibility is meaningful, though the lyophilized vial format remains the gold standard for sermorelin specifically given its short half-life and reconstitution-dependent stability.
9. Purity Peptides — North American Sourcing Chain
Site: puritypeptides.ca
Catalog focus: North American-sourced research peptides with per-batch documentation
Purity Peptides stands apart with an explicit North American sourcing narrative, marketed as North American sourced and 3rd-party tested (not China), with verified COAs and purity reports on every product. Their position is that peptide accuracy depends on synthesis quality, raw materials, and controlled production environments. Environmental exposure, temperature, and handling conditions directly affect molecular stability.
For Canadian sermorelin buyers working under institutional procurement requirements that mandate documented North American supply chains, Purity Peptides fits cleanly into that workflow. Their disclaimer language is research-clear: for laboratory research use only, not for human consumption.
10. VPeptide — Public Janoshik Batch Verification
Site: vpeptide.com
Catalog focus: Research peptides with public Janoshik batch verification
VPeptide carries a research peptide catalog with the framing ultra-pure, lab-tested, and double-verified peptide quality, supplied for laboratory research applications. The disclaimer language stays appropriately cautious throughout the catalog.
VPeptide publishes per-batch testing references through Janoshik Analytical’s public testing system, which is the third-party verification standard most researchers now look for. For sermorelin buyers who treat verifiable lab links as a non-negotiable requirement, VPeptide hits the bar.
11. PeptidePro Canada — Ontario-Based Dispatch
Site: peptideprocanada.com
Catalog focus: Focused catalog with central-Canada fulfillment speed
PeptidePro Canada offers a focused catalog with Ontario-based fulfillment. Products are usually supplied as lyophilized material in glass vials, shipped from Ontario, Canada, and provided strictly for non-clinical laboratory research by qualified facilities and trained personnel.
The Ontario-based fulfillment is a meaningful logistics edge for researchers in central Canada. Toronto, Ottawa, and Montreal labs typically see same-province or next-province delivery times within 1–2 business days. Certificates of Analysis are published directly on product pages alongside detailed quality information rather than gated behind email requests.
12. Boss Peptides — Educational Hub
Site: bosspeptides.ca
Catalog focus: Peptide catalog paired with extensive buyer-side educational content
Boss Peptides has built itself out partly as a supplier and partly as an educational resource. Their published verification framework lines up with serious 2026 standards: check for Health Canada approval, avoid injectable peptides sold without a prescription, and demand third-party testing. Legitimate research suppliers publish Certificates of Analysis (COAs) from independent labs, showing purity, identity, and sterility.
For sermorelin specifically, where the historical compound has gone through brand-name withdrawal and the 2026 sourcing reality is research-grade-only, Boss Peptides’ educational layer helps researchers understand the regulatory framework before sourcing decisions get made.
📊 Side-by-Side: Canadian Research-Grade Sermorelin Suppliers in 2026
| # | Supplier | Independent COA | Endotoxin Data | Full GH-Class Catalog | Differentiator |
|---|---|---|---|---|---|
| 1 | Nox Peptides | ✅ Public | ✅ Public | ✅ | Purity + endotoxin transparency |
| 2 | Growth Guys | ✅ Janoshik | On request | ✅ | GH-specialty + public verification |
| 3 | Canadian Peptides | ✅ | On request | ✅ | Long operating history; broad catalog |
| 4 | NCRP | ✅ | On request | Partial | Manufacturer-direct |
| 5 | Polar Peptides | ✅ | On request | ✅ | Education-heavy framing |
| 6 | Peptide Warehouse | ✅ | On request | ✅ | Combination GH-secretagogue blends |
| 7 | Clinical Peptides | ✅ | On request | ✅ | Loyalty rewards program |
| 8 | Amino Pure Canada | ✅ | On request | Partial | Multiple format options |
| 9 | Purity Peptides | ✅ Per-batch | On request | Partial | North American sourcing |
| 10 | VPeptide | ✅ Janoshik | On request | Partial | Public batch verification |
| 11 | PeptidePro Canada | ✅ Public on page | On request | Partial | Ontario-based dispatch |
| 12 | Boss Peptides | ✅ | On request | Partial | Educational hub depth |
📊 Research-Grade Sermorelin Pricing in Canada — 2026 Market Reality
| Vial Strength | Typical 2026 Canadian Range (CAD) | Per-Mg Range | Notes |
|---|---|---|---|
| 2mg | $50–$80 | ~$25–$40/mg | Entry research dose; lower upfront cost |
| 5mg | $70–$120 | ~$14–$24/mg | Common research format; balanced economics |
| 10mg | $100–$150 | ~$10–$15/mg | Better per-mg economics for ongoing research |
Sermorelin pricing typically sits at the lower end of the GH-secretagogue category. Meaningfully below tesamorelin (CAD $80–$200 per vial) and CJC-1295 with DAC (CAD $80–$160). That cost differential is one reason sermorelin stays competitive for high-volume research protocols despite its short half-life calling for more frequent administration.
Storage, Handling & Reconstitution: Sermorelin-Specific Notes
| Stage | Protocol |
|---|---|
| Receipt | Inspect packaging integrity; verify tamper-evident seals; refrigerate immediately |
| Lyophilized storage (short-term) | 2–8°C refrigeration, away from light |
| Lyophilized storage (long-term) | –20°C freezer, away from light |
| Reconstitution diluent | Bacteriostatic water, not plain sterile water for multi-use vials |
| Reconstitution technique | Inject diluent slowly down vial wall; gentle swirling, no aggressive shaking |
| Post-reconstitution storage | 2–8°C refrigerated; sermorelin reconstituted has a relatively short usable window, typically 2–3 weeks |
| Disposal | Per municipal hazardous waste guidelines |
One sermorelin-specific note: reconstituted sermorelin has a shorter post-reconstitution stability window than longer peptides. Plan reconstitution timing carefully. For protocols that need small volumes per administration, larger vials reconstituted once may not stay stable over the protocol duration.
📚 Authority Sources for Sermorelin Buyers
Before any purchase decision, every Canadian sermorelin buyer should review these primary sources:
- 🇨🇦 Health Canada — Drug Product Database (verify approved drugs and DINs)
- 🇨🇦 Health Canada — Think twice before injecting peptides bought online
- 📘 PubMed Central — Sermorelin: A Review of Its Use in Diagnostic Investigation of Growth Hormone Secretion
- 📘 PubMed — Original Sermorelin Pharmacology Studies (Frohman LA et al.)
- 📰 CBC News — Health Canada warns against unauthorized peptides (April 2026)
- ⚕️ College of Physicians & Surgeons of Alberta — Unauthorized injectable peptides
- 🎓 McMaster University — Research-Only Peptides Q&A
- 🎓 McGill University Office for Science and Society
- 🏃 World Anti-Doping Agency — Prohibited List
Frequently Asked Questions
Is sermorelin legal to buy in Canada?
Sermorelin is currently sold in Canada strictly within the research-chemical category. For laboratory research and in-vitro experimental use only. It’s not currently approved as a prescription drug by Health Canada (the original brand-name product Geref was pulled from market years ago and hasn’t been replaced). Selling or marketing sermorelin for human consumption is outside the legal framework.
Can I get a prescription for sermorelin in Canada?
No. As of 2026, no sermorelin product is currently approved by Health Canada with an active Drug Identification Number (DIN). The original Geref product (Serono) was pulled years ago. Canadian compounding pharmacies don’t widely compound sermorelin the way some US pharmacies do. Researchers studying sermorelin source from research peptide suppliers running within the research-use-only framework.
What’s the typical price for research-grade sermorelin in Canada?
Research-grade sermorelin pricing in 2026 typically runs from roughly CAD $50 to $150 per vial depending on dosage strength (2mg, 5mg, or 10mg) and supplier. Higher-dose vials offer better per-milligram economics, with 10mg vials typically in the ~$10–$15/mg range versus ~$25–$40/mg for 2mg formats.
Why is sermorelin cheaper than tesamorelin or CJC-1295 with DAC?
Two reasons. First, sermorelin is structurally simpler. At 29 amino acids versus tesamorelin’s 44 amino acids, synthesis is less complex and less expensive. Second, sermorelin is the original GHRH fragment without the structural modifications that extend half-life (DAC linkage in CJC-1295, stabilization modifications in tesamorelin). The simpler structure translates to lower per-vial pricing.
How does sermorelin’s short half-life affect research protocol design?
Sermorelin’s ~10–20 minute half-life means single doses produce a single discrete GH pulse rather than sustained elevation. Research protocols studying naturalistic GH pulse patterns benefit from this short-duration pharmacology. Protocols that need sustained GH elevation usually use longer-acting alternatives like CJC-1295 with DAC instead. The half-life difference is the central decision point in choosing between sermorelin and its longer-acting cousins.
Can I use sermorelin and ipamorelin in the same research protocol?
Yes. Combination protocols pairing GHRH analogs (sermorelin) with GHRPs (ipamorelin) are a well-established research category. The two compounds switch on different receptors (GHRH receptor vs ghrelin receptor) and produce synergistic GH release in research models. Some Canadian suppliers offer pre-formulated sermorelin + ipamorelin blends to simplify combination protocol procurement.
What’s the WADA status of sermorelin?
Sermorelin and other growth hormone-releasing factors are listed on the World Anti-Doping Agency Prohibited List. Athletes subject to WADA Code or any sport-governing-body anti-doping rules can’t source, possess, or use sermorelin in any form. Athletes should check with their compliance officer for current prohibited substance status before any procurement decision.
How does sermorelin compare to MK-677?
Different mechanism classes. Sermorelin is a GHRH analog (binds GHRH receptors at the pituitary). MK-677 is an oral ghrelin receptor agonist (binds ghrelin receptors). Both trigger GH release but through different pathways with different pharmacokinetic profiles. Sermorelin is a peptide that needs injection; MK-677 is a small molecule active orally. The two compounds are sometimes used in comparative GH-secretagogue research.
Is sermorelin still relevant in 2026 research given newer alternatives?
Yes, for specific applications. Sermorelin stays the reference compound for naturalistic pulsatile GH release research, sleep-cycle GH studies, and comparative GHRH analog research. Newer compounds (tesamorelin, CJC-1295 with DAC) offer better convenience and longer half-lives, but they don’t replicate sermorelin’s short-pulse pharmacology. For research questions that specifically need discrete GH pulses, sermorelin remains the right tool.
Can I import sermorelin from US suppliers?
Importing peptides into Canada from international sources carries CBSA seizure risk that’s been at record-high enforcement levels in 2026. Beyond seizure risk, peptides held in non-climate-controlled customs warehouses degrade quickly. Domestic Canadian sourcing avoids both problems and skips the regulatory complexity of cross-border peptide procurement.
⚖️ Legal Disclaimers
Research Use Only. All sermorelin products referenced in this article are sold and intended strictly for laboratory research and in vitro experimental use. They are not intended for human consumption, injection, ingestion, inhalation, topical application, or any other form of human use, nor for veterinary use, food, or cosmetic applications.
Not Currently Approved by Health Canada. Sermorelin is not currently approved as a drug by Health Canada. The original brand-name product (Geref, Serono) was pulled from the Canadian market years ago and hasn’t been replaced. Sermorelin doesn’t currently carry a Health Canada Drug Identification Number (DIN). Authorized drugs for sale in Canada carry an 8-digit DIN on the label.
No Active Prescription Pathway. No licensed physician in Canada can currently prescribe Health Canada-approved sermorelin, because no approved sermorelin product currently exists in the Canadian market. Any clinic claiming to provide prescription sermorelin in Canada is either running outside Canadian regulatory frameworks, importing from foreign markets without authorization, or compounding outside standard pharmacy practice. Buyers should verify regulatory authorization with the prescribing clinician and the College of Physicians & Surgeons in their province.
Health Canada Public Advisory. Health Canada has issued public advisories about unauthorized injectable peptide drugs sold online, citing risks including hormonal imbalance, mood swings, blood sugar imbalance, liver or kidney damage, blood clots, growth of cancerous tumours, infections, allergic reactions, and interactions with other medications. Readers are strongly encouraged to read the Health Canada advisory at canada.ca before any purchase decision.
No Medical Advice. This article is published for educational and informational purposes only. It doesn’t constitute medical advice, prescription guidance, diagnosis, or treatment recommendation. Anyone considering peptide-based therapies for personal health purposes should talk to a licensed Canadian healthcare professional.
Anti-Doping Compliance. Sermorelin and other growth hormone-releasing factors are listed on the World Anti-Doping Agency Prohibited List. Athletes subject to WADA Code or any sport-governing-body anti-doping rules should check with their compliance officer before sourcing or possessing any sermorelin compound.
Pricing Information. Pricing ranges referenced in this article are approximate and reflect publicly observed Canadian market data as of publication. Actual prices vary by supplier, batch, vial strength, and market conditions. Pricing information is provided for general orientation only, not as a quotation or guarantee.
Buyer Compliance. Buyers are solely responsible for compliance with all applicable federal, provincial, and municipal laws, regulations, and institutional policies in their jurisdiction, including Canada’s Food and Drugs Act, Controlled Drugs and Substances Act, Health Canada regulatory frameworks, and any institutional research ethics board (REB) requirements.
No Endorsement. The inclusion of any supplier in this guide reflects their public business activity in the Canadian research-use peptide market and does not constitute an endorsement, recommendation, or invitation to use sermorelin outside a controlled laboratory research setting.
No Liability. This publication, its authors, and Nox Peptides assume no liability for decisions made by readers based on the information provided herein. Sourcing decisions and any consequences thereof are the sole responsibility of the buyer.
The 2026 Bottom Line
Buying sermorelin in Canada in 2026 is a research-grade-only proposition. Unlike semaglutide, tirzepatide, or tesamorelin, where approved prescription products coexist alongside research-grade compounds, sermorelin currently has no Health Canada-approved product with an active DIN. The original brand-name Geref was pulled years ago and hasn’t been replaced.
For Canadian researchers studying GHRH analog pharmacology, pulsatile GH release patterns, sleep-cycle GH research, or comparative GH-secretagogue protocols, sermorelin stays the foundational reference compound. Its short half-life, natural-fragment structure, and well-characterized pharmacology, plus its lower per-vial cost compared to longer-acting alternatives, keep it relevant despite newer entrants in the GH-secretagogue category.
Nox Peptides sits at #1 on this list because the documentation depth on sermorelin, combined purity and endotoxin reporting per batch, is currently unmatched in the Canadian retail peptide market. The remaining eleven suppliers each have legitimate strengths for specific research needs: Janoshik public verification (Growth Guys, VPeptide), full GH-class catalog (Canadian Peptides), manufacturer-direct sourcing (NCRP), education-heavy framing (Polar Peptides), combination blend availability (Peptide Warehouse), loyalty rewards (Clinical Peptides), format flexibility (Amino Pure Canada), North American sourcing (Purity Peptides), Ontario-based dispatch (PeptidePro Canada), and educational depth (Boss Peptides).
What no Canadian buyer should compromise on in 2026: independent third-party COA verification, domestic Canadian shipping, clear research-use-only framing, and operational transparency. For a 29-amino-acid GHRH fragment with short post-reconstitution stability, those four criteria are the minimum baseline for serious research-grade sourcing.
For researchers ready to source from the documentation leader, browse the research-grade sermorelin listing and per-batch lab reports at noxpeptides.ca.
Last updated: 2026. Pricing, regulatory information, and supplier details current as of publication date and subject to change. Sermorelin’s regulatory status (no current Health Canada approval following Geref’s market withdrawal) is subject to change if any supplier seeks new authorization. Check Health Canada and the College of Physicians & Surgeons in your province for current guidance. All information provided for educational purposes only. Not medical advice.